Landos Biopharma (LABP) Stock Chart & Stock Price History → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free LABP Stock Alerts $21.76 +0.09 (+0.42%) (As of 04/18/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Landos Biopharma Stock Price Performance5 Day Performance+0.33%1 Month Performance+225.45%3 Month Performance+354.95%6 Month Performance+485.64%Year-To-Date Performance+490.44%1 Year Performance+619.37% Receive LABP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DTIThis company has increased its dividend every year for 54 yearsThere are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). LABP Stock Chart for Thursday, April, 18, 2024 LABP Chart by TradingView Landos Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2024$21.51$21.67+0.74%$21.72$21.4615,314 shs$67.61 million04/16/2024$21.57$21.51-0.28%$21.56$21.4319,143 shs$67.11 million04/15/2024$21.54$21.57+0.15%$21.57$21.4318,703 shs$67.30 million04/12/2024$21.51$21.54+0.14%$21.58$21.503,050 shs$67.21 million04/11/2024$21.56$21.51-0.21%$21.63$21.5135,409 shs$67.11 million04/10/2024$21.53$21.56+0.12%$21.60$21.4631,043 shs$67.25 million Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/09/2024$21.50$21.53+0.14%$21.59$21.4918,908 shs$67.17 million04/08/2024$21.61$21.50-0.51%$21.79$21.4734,509 shs$67.02 million04/05/2024$21.55$21.61+0.28%$21.64$21.4627,999 shs$67.42 million04/04/2024$21.49$21.55+0.28%$21.74$21.4518,593 shs$67.17 million04/03/2024$21.52$21.49-0.14%$21.67$21.4525,034 shs$67.05 million04/02/2024$21.60$21.52-0.37%$21.60$21.4538,699 shs$67.14 million04/01/2024$21.48$21.60+0.56%$21.76$21.4330,615 shs$67.39 million03/29/2024$21.50$21.48-0.09%$21.87$21.3547,103 shs$66.95 million03/28/2024$21.36$21.50+0.66%$21.82$21.3547,101 shs$67.08 million03/27/2024$21.56$21.36-0.93%$21.64$21.3544,644 shs$66.64 million03/26/2024$21.41$21.56+0.70%$21.80$21.3666,055 shs$67.27 million03/25/2024$7.83$21.41+173.44%$21.87$21.11570,043 shs$66.80 million03/22/2024$7.67$7.83+2.09%$8.08$7.707,105 shs$24.43 million03/21/2024$6.99$7.67+9.73%$7.90$7.0010,985 shs$23.93 million03/20/2024$6.94$6.99+0.72%$7.29$6.903,924 shs$21.81 million03/19/2024$6.64$6.94+4.52%$7.35$6.6418,645 shs$21.63 million03/18/2024$6.64$6.64$6.68$6.3110,867 shs$20.72 million03/15/2024$6.48$6.64+2.47%$6.64$6.302,837 shs$20.72 million03/14/2024$6.48$6.48$6.60$6.266,083 shs$20.20 million03/13/2024$6.53$6.48-0.77%$6.68$6.254,915 shs$20.22 million03/12/2024$6.25$6.53+4.48%$6.53$6.065,071 shs$20.37 million03/11/2024$6.24$6.25+0.16%$6.68$5.5721,315 shs$19.50 million03/08/2024$6.51$6.24-4.15%$6.64$6.0123,637 shs$19.47 million03/07/2024$6.61$6.51-1.51%$6.58$6.0047,492 shs$20.31 million03/06/2024$6.51$6.61+1.54%$6.73$6.413,906 shs$20.62 million03/05/2024$6.57$6.51-0.91%$6.63$6.395,736 shs$20.29 million03/04/2024$6.35$6.57+3.46%$6.57$6.2713,858 shs$20.50 million03/01/2024$6.34$6.35+0.16%$6.55$6.246,660 shs$19.81 million02/29/2024$6.36$6.34-0.31%$6.51$6.2017,412 shs$19.78 million02/28/2024$6.37$6.36-0.16%$6.38$6.202,242 shs$19.84 million02/27/2024$6.24$6.37+2.08%$6.41$6.1512,539 shs$19.87 million02/26/2024$6.29$6.24-0.79%$6.45$6.0125,301 shs$19.47 million02/23/2024$5.78$6.29+8.82%$6.45$5.8356,570 shs$19.63 million02/22/2024$5.78$5.78$5.78$5.3813,233 shs$18.03 millionThis company has increased its dividend every year for 54 years (Ad)There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free).02/21/2024$5.73$5.78+0.87%$5.89$5.576,958 shs$18.03 million02/20/2024$5.60$5.73+2.32%$5.80$5.4221,067 shs$17.86 million02/19/2024$5.60$5.60$5.60$5.60800 shs$17.47 million02/16/2024$5.46$5.51+0.92%$5.60$5.42816 shs$17.19 million02/15/2024$5.29$5.46+3.21%$5.47$5.259,039 shs$17.02 million02/14/2024$5.21$5.29+1.54%$5.47$5.168,855 shs$16.51 million02/13/2024$5.40$5.21-3.52%$5.47$4.838,447 shs$16.26 million02/12/2024$5.18$5.40+4.25%$5.40$5.252,303 shs$16.85 million02/09/2024$5.18$5.31+2.51%$5.31$5.164,436 shs$16.57 million02/08/2024$5.20$5.18-0.38%$5.31$5.161,931 shs$16.16 million02/07/2024$5.33$5.20-2.44%$5.30$5.203,364 shs$16.22 million02/06/2024$5.45$5.33-2.20%$5.41$5.223,283 shs$16.63 million02/05/2024$5.28$5.45+3.22%$5.62$5.2322,592 shs$16.99 million02/02/2024$5.39$5.28-2.04%$5.40$4.606,105 shs$16.47 million02/01/2024$5.39$5.39$5.46$5.0810,850 shs$16.82 million01/31/2024$4.98$5.39+8.23%$5.47$4.889,341 shs$16.80 million01/30/2024$5.00$4.98-0.40%$5.13$4.687,042 shs$15.54 million01/29/2024$4.61$5.00+8.46%$5.24$4.6554,997 shs$15.60 million01/26/2024$4.78$4.61-3.56%$4.93$4.394,581 shs$14.37 million01/25/2024$4.55$4.78+5.05%$4.78$4.377,684 shs$14.91 million01/24/2024$4.68$4.55-2.78%$4.88$4.553,702 shs$14.20 million01/23/2024$4.85$4.68-3.51%$4.94$4.462,340 shs$14.60 million01/22/2024$4.72$4.85+2.86%$4.85$4.585,609 shs$15.13 million01/19/2024$4.75$4.72-0.63%$4.72$4.384,844 shs$14.73 million01/18/2024$4.40$4.75+7.95%$4.79$4.3036,711 shs$14.82 million01/17/2024$4.24$4.40+3.77%$4.40$4.157,705 shs$13.73 million Related Companies: Kronos Bio Stock Price Chart Equillium Stock Price Chart Q32 Bio Stock Price Chart Checkpoint Therapeutics Stock Price Chart Anebulo Pharmaceuticals Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Immuneering Stock Price Chart Rallybio Stock Price Chart SCYNEXIS Stock Price Chart MediciNova Stock Price Chart Receive LABP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LABP) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.